328 related articles for article (PubMed ID: 10229810)
1. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells.
Kaliyaperumal A; Michaels MA; Datta SK
J Immunol; 1999 May; 162(10):5775-83. PubMed ID: 10229810
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
Sainis K; Datta SK
J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
[TBL] [Abstract][Full Text] [Related]
3. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
Mohan C; Shi Y; Laman JD; Datta SK
J Immunol; 1995 Feb; 154(3):1470-80. PubMed ID: 7529804
[TBL] [Abstract][Full Text] [Related]
4. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus.
Kaliyaperumal A; Mohan C; Wu W; Datta SK
J Exp Med; 1996 Jun; 183(6):2459-69. PubMed ID: 8676066
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor V beta genes expressed by IgG anti-DNA autoantibody-inducing T cells in lupus nephritis: forbidden receptors and double-negative T cells.
Adams S; Zordan T; Sainis K; Datta S
Eur J Immunol; 1990 Jul; 20(7):1435-43. PubMed ID: 2143726
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor alpha-chain repertoire of pathogenic autoantibody-inducing T cells in lupus mice.
Mao C; Osman GE; Adams S; Datta SK
J Immunol; 1994 Feb; 152(3):1462-70. PubMed ID: 8301146
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
Early GS; Zhao W; Burns CM
J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
[TBL] [Abstract][Full Text] [Related]
8. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
Hahn BH; Singh RR; Wong WK; Tsao BP; Bulpitt K; Ebling FM
Arthritis Rheum; 2001 Feb; 44(2):432-41. PubMed ID: 11229475
[TBL] [Abstract][Full Text] [Related]
9. Treatment of murine lupus using nucleosomal T cell epitopes identified by bone marrow-derived dendritic cells.
Suen JL; Chuang YH; Tsai BY; Yau PM; Chiang BL
Arthritis Rheum; 2004 Oct; 50(10):3250-9. PubMed ID: 15476240
[TBL] [Abstract][Full Text] [Related]
10. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion.
Carteron NL; Schimenti CL; Wofsy D
J Immunol; 1989 Mar; 142(5):1470-5. PubMed ID: 2521880
[TBL] [Abstract][Full Text] [Related]
11. Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR x NZB)F1 murine model.
Stoll ML; Price KD; Silvin CJ; Jiang F; Gavalchin J
J Autoimmun; 2007 Aug; 29(1):30-7. PubMed ID: 17459659
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model.
Ando DG; Sercarz EE; Hahn BH
J Immunol; 1987 May; 138(10):3185-90. PubMed ID: 2952711
[TBL] [Abstract][Full Text] [Related]
13. Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice.
Sun D; Krishnan A; Su J; Lawrence R; Zaman K; Fernandes G
Cell Immunol; 2004 Mar; 228(1):54-65. PubMed ID: 15203320
[TBL] [Abstract][Full Text] [Related]
14. Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice.
DeHeer DH; Edgington TS
J Immunol; 1976 Apr; 116(4):1051-8. PubMed ID: 1082901
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
Wu HY; Monsonego A; Weiner HL
J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816
[TBL] [Abstract][Full Text] [Related]
16. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
17. T cell tolerance to self antigens in New Zealand hybrid mice with lupus-like disease.
Kotzin BL; Kappler JW; Marrack PC; Herron LR
J Immunol; 1989 Jul; 143(1):89-94. PubMed ID: 2786535
[TBL] [Abstract][Full Text] [Related]
18. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK
Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
[TBL] [Abstract][Full Text] [Related]
19. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets.
Kang HK; Michaels MA; Berner BR; Datta SK
J Immunol; 2005 Mar; 174(6):3247-55. PubMed ID: 15749855
[TBL] [Abstract][Full Text] [Related]
20. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice.
Nakajima A; Hirose S; Yagita H; Okumura K
J Immunol; 1997 Feb; 158(3):1466-72. PubMed ID: 9013993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
